Editor's Note The US Food and Drug Administration (FDA) has deemed Smiths Medical’s recall of Proport Plastic Implantable Ports a Class 1, the most severe designation indicating serious risk of injury or death. The devices are designed for repeated venous access for injections, infusions, and/or blood samples. According to the…
Editor's Note Endovascular devices used to block aneurysm blood flow are the subject of the latest recall to be designated Class 1—the most severe designation indicating serious risk of injury or death—by the US Food and Drug Administration (FDA). As detailed in the agency’s March 18 announcement, Medtronic Neurovascular is…
Editor's Note Chief data officer (CDO) is a fast-growing C-suite role across the economy, with the notable exception of healthcare. The reasons why might be surprising: these roles have already been filled. Rather than growing, they are evolving. That’s the primary message of a March 4 report in Becker’s Hospital…
Editor's Note Hospitals are making measurable strides in patient safety and workforce resilience, but sustained focus is needed to maintain progress, according to a March 13 report in Chief Healthcare Executive. The article focuses on a new analysis from the American Hospital Association (AHA) and Press Ganey. Based on responses…
Editor's Note A new partnership between OrganOx and ProCure On-Demand aims to increase the number of viable donor livers for transplantation by combining advanced perfusion technology with expert recovery services, Fierce Healthcare reported March 17. The collaboration seeks to reduce the number of discarded organs and improve transplant success rates…
Editor's Note Although hospitals are already integrating artificial intelligence (AI), nurses warn that the technology may undermine their expertise and compromise patient care, The Associated Press (AP) reported March 16. The push for AI in healthcare stems from widespread nursing shortages. More than 100,000 nurses left the workforce during the…
Editor's Note Miniaturized pacemakers implanted in neonates and infants have demonstrated reliable performance for up to two years, with no unexpected device failures, according to a March 11 article in Healio. The research, published in Circulation: Arrhythmia and Electrophysiology, suggests that these modified pacemakers could offer a viable alternative for…
Editor's Note Multiple states seek to limit corporate influence in medicine by instituting additional checks on private equity-driven healthcare mergers, according to a March 17 report in Axios. Referencing multiple state-specific reports, the article summarizes specific efforts in Massachusetts, where a new law expands oversight of transactions; Maine, where a…
Editor's Note From operational efficiency and budgetary concerns to staffing issues and vendor relationships, the day-to-day concerns of perioperative professionals are fully reflected in the agenda for the 2025 OR Manager Conference, scheduled for October 28-30 in Anaheim, California. The line-up of in-depth, targeted educational sessions is divided into seven…
Editor's Note Preoperative use of GLP-1 receptor agonists was not significantly associated with an increased risk of aspiration pneumonia or acute respiratory failure after surgery, according to a March 4 report in MedPage Today. The article focuses on a retrospective cohort study of over 366,000 surgical patients found no meaningful…